Share & more
A clinical trial has shown that combination generic AIDS drugs are as effective as brand-name drugs and could provide hope for cheaper medicines in developing countries, British medical weekly, The Lancet, reports.
Conducted in Cameroon by the French Institut de Recherche Pour le Developpement, the six-month study found that 80 percent of the 60 HIV-positive respondents had an undetectable viral load after six months of taking two combo-pills a day.
"The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources," researchers said.
The 3-in-one pill replicates the AIDS cocktail recommended by the World Health Organisation (WHO) since 2002.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions